Marksans Pharma completes the acquisition from Tevapharm India
1 month ago•Free Press Journal
Profit Protection Strategy: Tata Elxsi and Tata Consumer Products Under the Spotlight
1 month ago•The Hindu Businessline
Broker’s Call: Marksans Pharma (Buy)
2 months ago•The Hindu Businessline
Marksans Pharma - With Focus On Backward Integration, Operating Margin Is Expected To Improve: HDFC Securities
2 months ago•Bloomberg Quint
Marksans Pharma climbs 2% after USFDA approval for Famotidine tablets
2 months ago•Moneycontrol
Marksans Pharma gets USFDA nod for generic version of Famotidine tablets
2 months ago•Business Standard
Marksans Pharma gets final USFDA nod for generic version of Famotidine tablets
2 months ago•Economic Times